Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: a meta-analysis and meta-regression
CEO/Chair, Council of Experts Topics The Basics Management The FutureScience The FuturePutting It Together Topics The Basics Management The FutureScience The FuturePutting It Together Key Elements of Science & Standards Division: Organization Flow Drivers for Change Increase/improve interface between different parts of USP Increase efficiency on work flow within SSD External to USP Internal within USP Expert Committees were recently restructured to manage monographs and reference standards To make project ownership for each product clear (single point of accountability in the context of the team) Maximize capacity of our work load (identify constraints and provide solutions) Drivers For Change: Outcomes Products (monographs, reference materials) to our customers are synchronized and reference standards are available as early as possible There is a portfolio owner for each segment of the portfolio for Small Molecules, Biologics, Excipients, Dietary Supplements, Food Ingredients, General Chapters/Pharmacists Pharmacopeia, Healthcare Quality Standards A uniform criteria for priority setting
local inflammations and allergic reactions
Be wary of clinics promising unrealistic outcomes with no mentioned downsides
The review is the first to compare efficacy of the three FDA-approved GLP-1 medications in nondiabetic patients using the drugs for weight loss
The hospital pharmacies segment held a 28% share of the market in 2025 and is expected to grow at a CAGR of 8.5% during the projection period
